Calamos Advisors LLC Baxter International Inc Transaction History

Calamos Advisors LLC

$16.1 Billion
Q3 2024

A detailed history of Calamos Advisors LLC transactions in Baxter International Inc stock. As of the latest transaction made, Calamos Advisors LLC holds 188,135 shares of BAX stock, worth $6.78 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

188,135

Previous 192,751 2.39%

Holding current value

$6.78 Million

Previous $6.45 Million 10.8%

% of portfolio

0.04%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$32.85 - $40.26 $151,635 - $185,840	-4,616 Reduced 2.39%	188,135 $7.14 Million
Q2 2024 Jul 25, 2024	SELL	$32.87 - $43.55 $231,273 - $306,417	-7,036 Reduced 3.52%	192,751 $6.45 Million
Q1 2024 May 08, 2024	SELL	$37.88 - $43.77 $190,347 - $219,944	-5,025 Reduced 2.45%	199,787 $8.54 Million
Q4 2023 Jan 31, 2024	SELL	$31.71 - $38.95 $84,855 - $104,230	-2,676 Reduced 1.29%	204,812 $7.92 Million
Q1 2023 May 03, 2023	SELL	$37.58 - $52.57 $974,787 - $1.36 Million	-25,939 Reduced 11.11%	207,488 $8.42 Million
Q4 2022 Jan 25, 2023	SELL	$49.7 - $57.71 $2.05 Million - $2.38 Million	-41,271 Reduced 15.02%	233,427 $0
Q2 2022 Aug 01, 2022	BUY	$63.83 - $80.0 $472,150 - $591,760	7,397 Added 2.77%	274,698 $17.6 Million
Q1 2022 May 03, 2022	BUY	$76.85 - $89.45 $2.74 Million - $3.18 Million	35,599 Added 15.36%	267,301 $20.7 Million
Q4 2021 Feb 01, 2022	SELL	$74.57 - $87.19 $3.05 Million - $3.57 Million	-40,929 Reduced 15.01%	231,702 $19.9 Million
Q3 2021 Oct 26, 2021	SELL	$73.77 - $83.61 $19 Million - $21.5 Million	-257,571 Reduced 48.58%	272,631 $21.9 Million
Q2 2021 Jul 22, 2021	BUY	$80.5 - $88.01 $8.95 Million - $9.79 Million	111,232 Added 26.55%	530,202 $42.7 Million
Q1 2021 Apr 12, 2021	BUY	$76.38 - $86.03 $304,603 - $343,087	3,988 Added 0.96%	418,970 $35.3 Million
Q4 2020 Jan 27, 2021	SELL	$75.39 - $82.36 $1.42 Million - $1.55 Million	-18,827 Reduced 4.34%	414,982 $33.3 Million
Q3 2020 Oct 26, 2020	SELL	$78.33 - $90.73 $4.08 Million - $4.72 Million	-52,069 Reduced 10.72%	433,809 $34.9 Million
Q2 2020 Jul 27, 2020	SELL	$78.66 - $94.14 $16.5 Million - $19.8 Million	-209,815 Reduced 30.16%	485,878 $41.8 Million
Q1 2020 Apr 28, 2020	SELL	$71.57 - $93.3 $19 Million - $24.8 Million	-265,625 Reduced 27.63%	695,693 $56.5 Million
Q4 2019 Jan 15, 2020	SELL	$76.7 - $88.45 $357,498 - $412,265	-4,661 Reduced 0.48%	961,318 $80.4 Million
Q3 2019 Oct 21, 2019	BUY	$81.4 - $89.78 $1.65 Million - $1.82 Million	20,321 Added 2.15%	965,979 $84.5 Million
Q2 2019 Aug 07, 2019	SELL	$73.44 - $82.41 $12.4 Million - $13.9 Million	-168,720 Reduced 15.14%	945,658 $77.4 Million
Q1 2019 Apr 12, 2019	SELL	$64.48 - $81.31 $3.39 Million - $4.27 Million	-52,555 Reduced 4.5%	1,114,378 $90.6 Million
Q4 2018 Jan 24, 2019	SELL	$61.45 - $77.8 $11.6 Million - $14.7 Million	-188,799 Reduced 13.93%	1,166,933 $76.8 Million
Q3 2018 Oct 22, 2018	BUY	$70.71 - $77.75 $664,037 - $730,150	9,391 Added 0.7%	1,355,732 $105 Million
Q2 2018 Jul 17, 2018	BUY	$63.43 - $75.41 $1.32 Million - $1.57 Million	20,858 Added 1.57%	1,346,341 $99.4 Million
Q1 2018 Apr 13, 2018	SELL	$62.56 - $72.26 $1.14 Million - $1.31 Million	-18,173 Reduced 1.35%	1,325,483 $86.2 Million
Q4 2017 Feb 13, 2018	BUY	$61.45 - $66.05 $2.83 Million - $3.04 Million	46,047 Added 3.55%	1,343,656 $86.9 Million
Q3 2017 Oct 25, 2017	SELL	$59.5 - $64.61 $4.5 Million - $4.88 Million	-75,582 Reduced 5.5%	1,297,609 $81.4 Million
Q2 2017 Aug 09, 2017	BUY	N/A	1,373,191	1,373,191 $83.1 Million

Others Institutions Holding BAX

# of Institutions

996

Shares Held

449M

Call Options Held

1.97M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.2B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Account

Calamos Advisors LLC Baxter International Inc Transaction History